AAAAAA
Results: 1-25/41
Authors:
Ballantyne, CM
Citation: Cm. Ballantyne, Surrogate endpoints and newer risk markers in atherosclerosis management, AM J M CARE, 7(5), 2001, pp. S144-S147
Authors:
Briaud, SA
Ding, ZM
Michael, LH
Entman, ML
Daniel, S
Ballantyne, CM
Citation: Sa. Briaud et al., Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice, AM J P-HEAR, 280(1), 2001, pp. H60-H67
Authors:
Ballantyne, CM
Citation: Cm. Ballantyne, Newer risk markers and surrogate endpoints in atherosclerosis management, CLIN CARD, 24(8), 2001, pp. 13-17
Authors:
Ballantyne, CM
Citation: Cm. Ballantyne, Treating mixed dyslipidemias: Why and how, CLIN CARD, 24(7), 2001, pp. II6-II9
Authors:
Ballantyne, CM
Pazzucconi, F
Pinto, X
Reckless, JP
Stein, E
McKenney, J
Bortolini, M
Chiang, YT
Citation: Cm. Ballantyne et al., Efficacy and tolerability of fluvastatin extended-release delivery system:A pooled analysis, CLIN THER, 23(2), 2001, pp. 177-192
Authors:
Hoogeveen, RC
Ballantyne, CM
Pownall, HJ
Opekun, AR
Hachey, DL
Jaffe, JS
Oppermann, S
Kahan, BD
Morrisett, JD
Citation: Rc. Hoogeveen et al., Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients, TRANSPLANT, 72(7), 2001, pp. 1244-1250
Authors:
Prince, JE
Brayton, CF
Fossett, MC
Durand, JA
Kaplan, SL
Smith, CW
Ballantyne, CM
Citation: Je. Prince et al., The differential roles of LFA-1 and Mac-1 in host defense against systemicinfection with Streptococcus pneumoniae, J IMMUNOL, 166(12), 2001, pp. 7362-7369
Authors:
Turban, S
Fuentes, F
Ferlic, L
Brugada, R
Gotto, AM
Ballantyne, CM
Marian, AJ
Citation: S. Turban et al., A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin, ATHEROSCLER, 154(3), 2001, pp. 633-640
Authors:
Lutucuta, S
Ballantyne, CM
Elghannam, H
Gotto, AM
Marian, AJ
Citation: S. Lutucuta et al., Novel polymorphisms in promoter region of ATP binding cassette transportergene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy, CIRCUL RES, 88(9), 2001, pp. 969-973
Authors:
Sharrett, AR
Ballantyne, CM
Coady, SA
Heiss, G
Sorlie, PD
Catellier, D
Patsch, W
Citation: Ar. Sharrett et al., Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions - The Atherosclerosis Risk in Communities (ARIC) Study, CIRCULATION, 104(10), 2001, pp. 1108-1113
Authors:
Fonarow, GC
Ballantyne, CM
Citation: Gc. Fonarow et Cm. Ballantyne, In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease - The time is now, CIRCULATION, 103(23), 2001, pp. 2768-2770
Authors:
Andrews, TC
Ballantyne, CM
Hsia, JA
Kramer, JH
Citation: Tc. Andrews et al., Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins, AM J MED, 111(3), 2001, pp. 185-191
Authors:
Ballantyne, CM
Andrews, TC
Hsia, JA
Kramer, JH
Shear, C
Citation: Cm. Ballantyne et al., Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels, AM J CARD, 88(3), 2001, pp. 265-269
Authors:
Ballantyne, CM
Citation: Cm. Ballantyne, Case 4: Type 2 diabetes, hypertension, and dyslipidemia, AM J CARD, 87(4), 2001, pp. 503
Authors:
Ballantyne, CM
Citation: Cm. Ballantyne, Statins after cardiac transplantation: Which statin, what dose, and how low should we go?, J HEART LUN, 19(6), 2000, pp. 515-517
Authors:
Elghannam, H
Tavackoli, S
Ferlic, L
Gotto, AM
Ballantyne, CM
Marian, AJ
Citation: H. Elghannam et al., A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy, J MOL MED-J, 78(10), 2000, pp. 562-568
Authors:
Ballantyne, CM
Herd, JA
Stein, EA
Ferlic, LL
Dunn, JK
Gotto, AM
Marian, AJ
Citation: Cm. Ballantyne et al., Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy, J AM COL C, 36(5), 2000, pp. 1572-1578
Authors:
Marian, AJ
Safavi, F
Ferlic, L
Dunn, JK
Gotto, AM
Ballantyne, CM
Citation: Aj. Marian et al., Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin - The lipoprotein and coronary atherosclerosis study, J AM COL C, 35(1), 2000, pp. 89-95
Authors:
Nossuli, TO
Lakshminarayanan, V
Baumgarten, G
Taffet, GE
Ballantyne, CM
Michael, LH
Entman, ML
Citation: To. Nossuli et al., A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies, AM J P-HEAR, 278(4), 2000, pp. H1049-H1055
Authors:
Choi, YJ
Baranowska-Daca, E
Nguyen, V
Koji, T
Ballantyne, CM
Sheikh-Hamad, D
Suki, WN
Truong, LD
Citation: Yj. Choi et al., Mechanism of chronic obstructive uropathy: Increased expression of apoptosis-promoting molecules, KIDNEY INT, 58(4), 2000, pp. 1481-1491
Authors:
Kubo, N
Boisvert, WA
Ballantyne, CM
Curtiss, LK
Citation: N. Kubo et al., Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice, J LIPID RES, 41(7), 2000, pp. 1060-1066
Authors:
Frangogiannis, NG
Mendoza, LH
Lindsey, ML
Ballantyne, CM
Michael, LH
Smith, CW
Entman, ML
Citation: Ng. Frangogiannis et al., IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury, J IMMUNOL, 165(5), 2000, pp. 2798-2808
Authors:
Simon, DI
Chen, ZP
Xu, H
Li, CQ
Dong, JF
McIntire, LV
Ballantyne, CM
Zhang, L
Furman, MI
Berndt, MC
Lopez, JA
Citation: Di. Simon et al., Platelet glycoprotein Ib alpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18), J EXP MED, 192(2), 2000, pp. 193-204
Authors:
Simon, DI
Chen, ZP
Seifert, P
Edelman, ER
Ballantyne, CM
Rogers, C
Citation: Di. Simon et al., Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty, J CLIN INV, 105(3), 2000, pp. 293-300
Authors:
Ballantyne, CM
Grundy, SM
Oberman, A
Kreisberg, RA
Havel, RJ
Frost, PH
Haffner, SM
Citation: Cm. Ballantyne et al., Hyperlipidemia: Diagnostic and therapeutic perspectives, J CLIN END, 85(6), 2000, pp. 2089-2089